Citigroup
CMPX icon

Citigroup’s Compass Therapeutics CMPX Stock Holding History

Citigroup’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$640K Sell
615,135
-98,772
-14% -$204K ﹤0.01% 3604
2026
Q2 		$1.56M Buy
713,907
+115,669
+19% +$341K ﹤0.01% 3115
2026
Q1 		$3.16M Buy
598,238
+336,362
+128% +$1.94M ﹤0.01% 2325
2025
Q4 		$1.41M Buy
261,876
+251,225
+2,359% +$1.16M ﹤0.01% 2903
2025
Q3 		$37.3K Sell
10,651
-21,059
-66% -$66.5K ﹤0.01% 4583
2025
Q2 		$82.4K Sell
31,710
-99,527
-76% -$205K ﹤0.01% 4504
2025
Q1 		$249K Buy
131,237
+52,634
+67% +$140K ﹤0.01% 4068
2024
Q4 		$114K Buy
78,603
+4,322
+6% +$7.18K ﹤0.01% 4766
2024
Q3 		$137K Buy
74,281
+51,150
+221% +$63.8K ﹤0.01% 4611
2024
Q2 		$23.1K Buy
23,131
+6,089
+36% +$8.89K ﹤0.01% 4962
2024
Q1 		$33.7K Buy
17,042
+3,640
+27% +$6.29K ﹤0.01% 4830
2023
Q4 		$20.9K Buy
13,402
+13,219
+7,223% +$22.9K ﹤0.01% 4973
2023
Q3 		$361 Sell
183
-28,905
-99% -$71.5K ﹤0.01% 5250
2023
Q2 		$92.5K Sell
29,088
-113,853
-80% -$357K ﹤0.01% 4287
2023
Q1 		$467K Buy
142,941
+16,626
+13% +$65.3K ﹤0.01% 3171
2022
Q4 		$635K Buy
126,315
+121,782
+2,687% +$486K ﹤0.01% 2993
2022
Q3 		$10K Buy
4,533
+3,163
+231% +$8.76K ﹤0.01% 4980
2022
Q2 		$4K Buy
+1,370
New +$2.97K ﹤0.01% 5666
2022
Q1 		– Sell
-37,834
Closed -$120K – 6338
2021
Q4 		$120K Buy
+37,834
New +$125K ﹤0.01% 4638

Other funds holding CMPX

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Simplicity Wealth
Simplicity Wealth Summit, New Jersey $3.43B AUM 16.22% 1-Year Est. Return
Independent Financial Group
Independent Financial Group San Diego, California $5.51B AUM 33.51% 1-Year Est. Return
McAdam LLC
McAdam LLC Philadelphia, Pennsylvania $2.66B AUM 14.82% 1-Year Est. Return

Citigroup's CMPX Position: Q3 2026 in Review

Citigroup reduced its Compass Therapeutics (CMPX) stake by 14% in Q3 2026, selling an estimated $204K and leaving 615,135 shares worth $640K. The position accounts for ﹤0.01% of the portfolio, ranked #3604.

Citigroup first reported a position in CMPX in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.16M in Q1 2026. 33 funds tracked by Wall St. Rank hold CMPX as of Q3 2026.

  • Citigroup held 615,135 shares of Compass Therapeutics worth $640K as of Q3 2026.
  • Citigroup sold 98,772 Compass Therapeutics shares in Q3 2026, an estimated $204K.
  • Compass Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #3604 holding.
  • Citigroup first reported a position in Compass Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Citigroup's Compass Therapeutics position peaked at $3.16M in Q1 2026.
  • 33 funds tracked by Wall St. Rank held Compass Therapeutics as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.